- Home
- TIL vs RMAX Comparison
TIL vs RMAX Comparison
Compare TIL & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- RMAX
- Stock Information
- Founded
- TIL 2018
- RMAX 1973
- Country
- TIL United States
- RMAX United States
- Employees
- TIL N/A
- RMAX N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- RMAX Real Estate
- Sector
- TIL Health Care
- RMAX Finance
- Exchange
- TIL Nasdaq
- RMAX Nasdaq
- Market Cap
- TIL 177.1M
- RMAX 187.5M
- IPO Year
- TIL 2021
- RMAX 2013
- Fundamental
- Price
- TIL $20.99
- RMAX $8.44
- Analyst Decision
- TIL Strong Buy
- RMAX Hold
- Analyst Count
- TIL 5
- RMAX 1
- Target Price
- TIL $100.67
- RMAX $9.00
- AVG Volume (30 Days)
- TIL 165.7K
- RMAX 195.6K
- Earning Date
- TIL 11-12-2025
- RMAX 10-30-2025
- Dividend Yield
- TIL N/A
- RMAX N/A
- EPS Growth
- TIL N/A
- RMAX N/A
- EPS
- TIL N/A
- RMAX 0.48
- Revenue
- TIL N/A
- RMAX $298,162,000.00
- Revenue This Year
- TIL N/A
- RMAX N/A
- Revenue Next Year
- TIL N/A
- RMAX N/A
- P/E Ratio
- TIL N/A
- RMAX $17.48
- Revenue Growth
- TIL N/A
- RMAX N/A
- 52 Week Low
- TIL $10.80
- RMAX $6.90
- 52 Week High
- TIL $45.07
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- TIL 49.49
- RMAX 35.31
- Support Level
- TIL $17.37
- RMAX $8.33
- Resistance Level
- TIL $21.45
- RMAX $9.44
- Average True Range (ATR)
- TIL 1.48
- RMAX 0.28
- MACD
- TIL 0.47
- RMAX -0.19
- Stochastic Oscillator
- TIL 89.09
- RMAX 6.43
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.